
Desvenlafaxine Extended-Release Tablets 50 mg (Desvenlafaxine Besylate)
73.185mg
Tablet · Prescription medication
NexPharm Korea Co., Ltd.
Desvenlafaxine benzoate is an antidepressant ingredient used for the treatment of depression and anxiety disorders.
MFDS ingredient code M278470
Desvenlafaxine benzoate is a selective serotonin-norepinephrine reuptake inhibitor (SNRI) that inhibits the reuptake of serotonin and norepinephrine. It is primarily used for the treatment of depression and anxiety disorders.
This ingredient prevents the reuptake of serotonin and norepinephrine, neurotransmitters involved in mood regulation in the brain, thereby increasing their concentrations. As a result, neurotransmission is facilitated, alleviating symptoms of depression and anxiety.
Approved uses differ by product. Check each product's information for its actual use.
Desvenlafaxine benzoate acts on both serotonin and norepinephrine compared to other SNRI class medications, but its side effect profile may differ from specific medications. Additionally, this ingredient is characterized by acting as an active metabolite in the metabolic process.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
9 total

73.185mg
Tablet · Prescription medication
NexPharm Korea Co., Ltd.

146.37mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.

73.185mg
Tablet · Prescription medication
Myeongin Pharmaceutical Co., Ltd.

146.37mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

73.185mg
Tablet · Prescription medication
Hankook Pharmaceutical Co., Ltd.

146.37mg
Tablet · Prescription medication
Hanlim Pharmaceuticals Co., Ltd.

36.5925mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

36.5925mg
Tablet · Prescription medication
Hannim Pharmaceutical Co., Ltd.

36.5925mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.